Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma

Nearly 50% of uveal melanoma (UM) patients develop metastatic disease, and there remains no current standard assay for detection of minimal residual disease. We conducted a pilot study to check the feasibility of circulating tumor cell (CTC) detection in UM. We enrolled 40 patients with early or met...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Kartik, Roszik, Jason, Gombos, Dan, Upshaw, Joshua, Sarli, Vanessa, Meas, Salyna, Lucci, Anthony, Hall, Carolyn, Patel, Sapna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628316/
https://www.ncbi.nlm.nih.gov/pubmed/31226786
http://dx.doi.org/10.3390/cancers11060856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628316/
https://www.ncbi.nlm.nih.gov/pubmed/31226786
http://dx.doi.org/10.3390/cancers11060856

Ejemplares similares